Zurich Cantonal Bank
INBX icon

Zurich Cantonal Bank’s Inhibrx INBX Stock Holding History

Zurich Cantonal Bank’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.8K Buy
367
+173
+89% +$17.3K ﹤0.01% 2462
2026
Q1 		$13K Sell
194
-304
-61% -$22.6K ﹤0.01% 2470
2025
Q4 		$39.3K Hold
498
– – ﹤0.01% 2447
2025
Q3 		$16.8K Sell
498
-239
-32% -$5.88K ﹤0.01% 2483
2025
Q2 		$10.5K Sell
737
-87
-11% -$1.13K ﹤0.01% 2515
2025
Q1 		$11.5K Buy
824
+706
+598% +$9.59K ﹤0.01% 2583
2024
Q4 		$1.82K Hold
118
– – ﹤0.01% 2622
2024
Q3 		$1.85K Hold
118
– – ﹤0.01% 2640
2024
Q2 		$1.67K Buy
+118
New +$1.84K ﹤0.01% 2632

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Zurich Cantonal Bank's INBX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Inhibrx (INBX) stake by 89% in Q2 2026, buying an estimated $17.3K and bringing the position to 367 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2462.

Zurich Cantonal Bank first reported a position in INBX in Q2 2024 and has held it in 9 quarters since. The position peaked at $39.3K in Q4 2025. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Zurich Cantonal Bank held 367 shares of Inhibrx worth $34.8K as of Q2 2026.
  • Zurich Cantonal Bank bought 173 Inhibrx shares in Q2 2026, an estimated $17.3K.
  • Inhibrx made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2462 holding.
  • Zurich Cantonal Bank first reported a position in Inhibrx in Q2 2024 and has held it in 9 quarters since.
  • Zurich Cantonal Bank's Inhibrx position peaked at $39.3K in Q4 2025.
  • 163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.